Trending Now

All Articles

3210 Articles

Russian Oligarch’s Son Loses Bid to Hide Assets from Mother in Burford-Funded Case

The largest divorce settlement in Britain’s history is not over yet. Temur Akhmedov recently lost his effort to keep his money secret from his step-mother—who is still attempting to gain the award settlement from her divorce. Tatiana Akhmedova is utilizing litigation funding from Burford Capital as she pursues her claim. Daily Mail has revealed that Temur Akhmedov is displeased at his step-mother’s use of third-party funding, and had previously demanded that the terms of the funding be revealed. Meanwhile, his attempts to hide his personal financial records have fallen flat. Justice Gwynneth Knowles has ruled that no reasonable grounds were demonstrated that would necessitate challenging Mrs. Akhmedova’s funding arrangement. This is good news for proponents of litigation funding, even as Temur stated he would pursue the matter with an appeals court—which he asserted would be fairer to him. He went on to express frustration with the family court, implying that the ruling was ‘unfair.’ Akhmedov likened the British family court to ‘Imperialism’. To date, Mrs. Akhmedova has received roughly GPB 5 million of the 452 million awarded to her in the divorce—representing about 40% of her ex-husband’s business. Judges confirmed that Temur Akhmedov has not paid out any of his mother’s settlement voluntarily. Temur has stated that he does not recognize the British judge’s ruling because of his father and Tatiana’s 2000 divorce in Moscow.  

Curiam Capital Director Discusses Litigation Finance

Lauren Bernstein joined Curiam Capital LLC in March 2019. Her experience spans more than a decade. In this interview, she discusses starting her own business in 2014, why she chose to work in Litigation Finance, and how COVID impacts several parts of her life. In Bernstein’s interview with JD Supra, she explains that working at home due to COVID precautions was easier than anticipated. Having a routine helps her stay focused and productive. With regard to COVID, Bernstein welcomes resource centers that help clients and others make informed choices about financial, legal, and business matters. Ideally, she says, people should get their information from more than one source. Bernstein is a proponent of litigation funding and is prepared for a COVID-related spike in requests for funding. She details that funding may be a good option for clients with existing claims, especially when they are no longer able to pay legal fees. COVID promises to drive litigation in insurance and insolvency or breach of contract for commercial litigation in particular. In addition to the inconvenience of remote working, Bernstein understands that one of the main upcoming challenges is to find effective ways to quickly analyze new cases. Finding strong cases is likely to require sifting through more cases more efficiently than before. Speaking out against overregulation in Litigation Finance, Bernstein explains that she sees no necessity for judicial approval of funding. She referred to the conclusions of the New York City Bar Association’s working group, which was clear in saying that funders do not control litigation. She sees no difference between funders (which some feel should be disclosed) and borrowing money from banks (which need not be disclosed) in terms of necessary disclosure. When asked what advice she would give her younger self, Bernstein opined on the value of a good mentor.

Key Takeaways from LFJ’s Digital Conference on Covid’s Impact on Consumer Legal Funding

On June 11th, Litigation Finance Journal held a special digital conference on Covid's impact on the Consumer Legal Funding industry. The panel discussion was moderated by Dan Avnir (DA), Managing Director at Bryant Park Capital. Panelists included Eric Schuller (ES), President of the Alliance for Responsible Consumer Legal Funding (ARC), Kevin Confoy (KC), Chief Risk Officer of GloFin, Paul Galsterer (PG), Founding Partner of The Injury Firm, Lawrence Yablon (LY), Partner at Robinson Yablon PC, and Anthony Sebok (AS), Professor of Law and Co-Director of the Jacob Burns Center for Ethics in the Practice of Law at Benjamin N. Cardozo School of Law. Some key takeaways from the discussion are below: DA: In the current landscape of corporate liabilities, has there been a liability shift? LY: It is a big concern, especially for small businesses. I am pessimistic that this will be a lucrative area for funding or personal injury firms. That there will be laws put in place to protect businesses from further damage. They’ve suffered in the public’s mind, and now have lawyers coming after them because of a pandemic, which nobody predicted. As an underwriter, I’d be very hesitant to have my underwriting clients get involved in those types of cases—because of the optics, and ultimately there will be a fund to protect nursing homes and hospitals and such. But if businesses force their employees to come back, but without a plan in place—people will be less sympathetic to that, and you might see more cases. PG: It’s a very new area. I would think that there are going to be protections in place. I’d be extremely cautious about getting involved in that type of funding. DA: There’s been no shortage of suits, nursing home cases, or Enterprise Rent-a-car, etc. In 20 plus states, Governors have issued emergency orders that granted immunity from COVID-related lawsuits. How liable are companies, and how high might the burden of proof be in these cases? AS: In New York, the executive order related to health and health professionals. One of the missing pieces of the Litigation Finance market, even before COVID, was medical malpractice. The underlying tort law drivers aren’t really present here. I’d be cautious about predicting massive scale of new liability coming out of traditional tort law. The law itself isn’t going to be a big driver here. But the federal government may help with compensation.  DA: Are corporate liabilities specific to COVID a state or federal matter? What about a compensation fund for victims? AS: In the consumer sector, it will follow the pattern of claims in state court. I think that will continue. ES: On legislation that has passed, Ohio is a good example of what it will be like going forward. Unless a company was dramatically negligent, the company is protected from litigation. 3M, for example, said they wouldn’t ramp up PPE production without federal immunity from lawsuits. The Illinois governor made an executive order that if an essential worker came down with COVID, it will be assumed that they caught it at work and could file worker’s comp. Businesses didn’t like that, and that kind of thing will vary between blue and red states. DA: For which funders is this advice most applicable? KC: As we talked about, there’s a lot of uncertainty. Consider optics. More aggressive funders are more likely to get involved in COVID liability cases. More experienced lenders are likely to pass on these. DA: What were some of the key pressures facing originators pre-COVID, and how does COVID impact pending legislation? ES: COVID attracted focus in some state legislatures. All but 4-5 states shut down. The focus was on budget, and getting businesses open again over all other concerns. One aspect that could be a possibility is allowing companies to have tort protection. That has to include disclosures of contracts and funders—people will want to know who’s behind it. Legislators were nervous about how confident the litigation funders were. So that’s being used as an excuse for tort reform. KC: The only other legislation we’re concerned about is whether the federal government will continue to extend unemployment—because the result from that will drive business. DA: Would you say that plaintiff advances are more or less attractive in this environment? LY: You can make the argument on both sides. I’ve been bullish that the worst is behind us. Plaintiff personal injury is more or less recession-proof. Overall, it remains an attractive investment.

How Big is Litigation Finance?

How big is the addressable market for Litigation Finance? An exact number would be difficult to come up with. What we do know is that the $85 billion number asserted by Omni Bridgeway and others is the subject of much debate. It represents an estimate of the fees that were paid to plaintiff’s lawyers, but is not really indicative of the state of the entire market. Bloomberg Law explains that the Litigation Finance industry spent less than three percent of the suggested $85 billion between mid-2018-mid 2019. That might indicate, as many have speculated, that the industry is about to experience a spike in popularity. Allison Chock, US investment officer at Omni Bridgeway, has stated that she doesn’t expect the industry to reach the $85 billion capacity any time soon.   Some say litigation funders ought not to even try to reach maximum capacity—especially if it means providing a glut of funding for every plaintiff who asks. That would carry a lot more risk than carefully selecting cases. Besides, if the argument in favor of third-party finance is that it increases access to justice for those of modest means, it’s undercut by the idea of gambling on the odds. For Litigation Finance to remain a viable industry, it has to focus on helping meritorious cases triumph over well-monied entities whose size and clout make them virtually indestructible. Indeed, the David and Goliath model should be the most attractive to investors. Howard Shams, CEO of Parabellum, is more cautious about the state of the industry. He has stated that while the market is growing, it’s far from infinite. Firms should not act as if it’s a free-for-all.

ALFA Applauds Minnesota Supreme Court’s Ruling Affirming Consumer Legal Funding

June 11, 2010 - Last week, the Minnesota Supreme Court affirmed consumer litigation funding in Minnesota, finding that champerty, the English common law doctrine prohibiting disinterested third parties from providing money to plaintiffs in exchange for an interest in their case no longer applies.
“The American Legal Finance Association (ALFA) applauds the Minnesota Supreme Court’s decision to eliminate the application of this outdated doctrine to consumer legal funding. Minnesota is joining the ranks of states that understand the important role of consumer legal funding in helping victims access justice.” said Kelly Gilroy, Executive Director of ALFA.
Despite a lower court decision voiding a funding contract, the Minnesota Supreme Court wrote in their decision “We decline, however, to hold that the contract between Maslowski and Prospect is void as against public policy as we understand it today.” The court’s decision in Pamela Maslowski vs. Prospect Funding Partners LLC et al resolves the question in Minnesota that the doctrine of champerty does not prohibit consumer litigation funding and ensures that victims in Minnesota will continue to safely access this crucial financial resource. The court remanded the case to the district court for final disposition.
Consumer legal funding helps level the playing field for victims pursuing justice through the courts. A pre-settlement advance offers immediate financial relief to victims for use on non-legal expenses — including groceries, medical bills, student loans, and rent. For victims facing powerful defendants with the ability to slow-walk a case, legal funding helps relieve financial pressure and prevent the premature abandonment of the case.
ALFA supports common-sense regulation that provides oversight, accountability, and transparency in the industry and protects access to this critical resource for consumers.
Read More

LexShares Launches $100 Million Litigation Finance Fund

LexShares, a leader in commercial litigation finance, today announced the launch of LexShares Marketplace Fund II (LMFII). With a $100 million target fund size, LMFII will invest in litigation-related assets offered on the LexShares platform. LMFII opens on the heels of the company’s 100th legal claim investment, making LexShares one of the most active litigation funding firms in the world. The firm closed LexShares Marketplace Fund I in January 2018, which was fully subscribed for $25 million. Prior to this public launch, LMFII received commitments in excess of $30 million, which includes two cornerstone institutional investors. LMFII is now accepting commitments from both institutional and individual accredited investors at lexshares.com. “Six years ago, we founded LexShares. Two years ago, we launched our first dedicated litigation finance fund. Today, underpinned by a proven track record and an increasingly strong pipeline of investment opportunities, we continue our mission of providing investors unparalleled access to high-quality investments in litigation finance--a traditionally hard-to-access asset class,” said Co-Founder and Chief Executive Officer, Jay Greenberg. “We are thankful for the support we have received from our community of investors who entrust us as stewards of their capital. Their confidence and enthusiasm have enabled us to establish this milestone Fund II.” As of June 10, LexShares has invested in 103 case offerings. Of those, 43 investments have resolved, resulting in a 52% median IRR net of fees and expenses. Over the past year, LexShares’ average investment per case offering was $1,460,607, up from $845,250 the year prior. Investments as of January 1, 2019 represent 48% of all capital deployed since the firm was founded in 2014. LexShares’ proprietary origination technology platform, the Diamond Mine, has sourced more than one million case investment opportunities since the company launched the software in 2016. As a result, LexShares’ in-house investment team has collectively underwritten over $2.63 billion in funding opportunities--$855 million in the past year alone. “Demand for litigation funding has grown dramatically since we founded LexShares,” explained Co-Founder and Chief Investment Officer, Max Volsky. “To date, we have had a great deal of success in servicing the commercial litigation finance middle market. LMFII positions us to invest in a greater number of commercial cases as well as offer portfolio funding and other novel financial products to our growing network of law firms.” Accredited investors are now able to access the LexShares Marketplace Fund II investor presentation, and invest directly on LexShares’ website. About LexShares LexShares is a leading litigation finance firm, with an innovative approach to originating and financing high-value commercial legal claims. LexShares funds litigation-related matters, primarily originated by its proprietary Diamond Mine software, through both its online marketplace and dedicated litigation finance fund. Founded in 2014, the company is privately owned with principal offices in Boston and New York City. For more information, visit lexshares.com. About LexShares Marketplace Fund II LexShares Marketplace Fund II (LMFII) is the company’s second discretionary fund dedicated to providing access to a portfolio of litigation-related assets. LMFII has retained Seward & Kissel LLP as its legal counsel, BDO USA, LLP for tax and auditing services, and SS&C Technologies Inc. as its fund administrator. Additionally, LMFII has secured a principal protection insurance policy from AmTrust International Insurance, Ltd., an industry-leading global insurance provider. Investors can elect to cover all or a portion of their commitment to LMFII with this policy. LMFII is now open for investment directly on lexshares.com. This release may contain “forward looking statements” which are not guaranteed. Investment opportunities posted on LexShares are offered by WealthForge Securities, LLC, a registered broker-dealer and member FINRA / SIPC. LexShares and WealthForge are separate entities. This release does not constitute an offer to sell or the solicitation of any offer to buy interests in the LexShares Marketplace Fund II (LMFII), which may only be made at the time a qualified subscriber receives the confidential investor packet (the “Investor Packet”) which includes the confidential private placement memorandum of LMFII, describing the offering. The interests in LMFII shall not be offered or sold in any jurisdiction in which such an offer or sale would be unlawful until the requirements of the laws of such jurisdiction have been satisfied. In the case of any inconsistency between the descriptions or terms in this release and the Investor Packet, the Investor Packet shall control. Each prospective investor should consult its own attorney, business adviser and tax adviser as to legal, business, tax and related matters concerning the information contained herein. Investment opportunities offered by LexShares are “private placements'' of securities that are not publicly traded, are not able to be voluntarily redeemed or sold, and are intended for investors who do not need a liquid investment. Investors must be able to afford the loss of their entire investment without a change to their lifestyle. Historical performance information is not indicative of future performance or investment returns, and prospective investors should not view the performance information as an indicator of the future performance of LMFII. Investments in legal claims are speculative, carry a high degree of risk and may result in loss of entire investment. Returns are based on principal’s internal reporting for offerings through the LexShares platform reaching resolution as of June 10, 2020. Results reported reflect the simple median annualized rate of return per the xirr function, net of fees and expenses. The insurance protection policy is subject to terms and conditions which should be reviewed in full in the Investor Packet and considered before a decision is made to proceed with insurance protection.
Read More

Investor Evolution in Commercial Litigation Finance

The following article is part of an ongoing column titled ‘Investor Insights.’  Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance.  EXECUTIVE SUMARY
  • The investor base in litigation finance continues to evolve
  • The asset class is becoming more institutional as it produces more data and enhances transparency
  • Litigation finance is entering its institutional capital phase
INVESTOR INSIGHTS
  • Restrictive capital sources will be replaced by less restrictive capital sources
  • Fund managers must ensure their equity value is not impaired through their fundraising decisions
  • Investors should monitor supply / demand characteristics of the asset class to ensure pricing is not eroded through excess capital supply
As with any new industry, there is much risk and trepidation with respect to whether (i) the concept will work, (ii) the concept will be profitable, (iii) the concept will be scalable and (iv) the concept will attract investment support.  Oh, and in the case of litigation finance, (v) whether the concept is in fact legal. Let’s tackle legality first.  Without going into a long dissertation on champerty, maintenance and barratry, justice systems around the world have understood the stark reality of the construct of their respective modern day justice systems. That is to say, the playing field is in no way even – it is markedly tilted in favour of those parties with deep pockets that can afford some of the best lawyers in the world.  Recognizing the inequality of their own systems, the fact that litigation costs are increasing at more than three times the rate of inflation (about 9% per annum in the US), and the fact that litigation is being used as a business tool to extract advantage, justice systems globally have been increasingly receptive to a third party providing financing to support “David” in his fight against “Goliath”.  The outcome of this global judicial reform (mainly driven by precedent, but in some cases by legislation) is that the little guy is fighting back and now stands a chance at winning against the large corporation which has much more time, money and resources at its disposal. The trend is strong and increasing, so much so that it has become a political issue in certain jurisdictions (as evidenced by Australia’s recent ruling to force funders to become licensed), and has attracted regulation in both consumer and commercial segments of the market.  One could cite efforts by many funders, including Omni Bridgeway (formerly IMF Bentham) in Australia (and recently in Canada – Bluberi) and Burford Capital in the USA, for funding cases that ultimately went on to create an environment in which litigation finance has flourished.  And the industry is just getting started. As it relates to the first three concerns about whether the concept will work, will it be profitable and is it scalable, empirical results indicate that the answer has been a resounding “YES!” to all three. So, let’s take a deeper look at how the industry got to the point where it was able to validate litigation finance as an asset class, how the investor base has evolved over time, and what the implications are for the investors of the future. Humble Beginnings Risky strategies attract risky money.  In the early days of most litigation finance funds, fund managers are selling a concept and their own capabilities, but not much else.  When the risk level is that high, it attracts a certain type of capital.  On the one hand, it attracts high net worth individual capital that has been created by those who have taken a certain degree of risk in creating their own nest eggs and are very comfortable assuming similar risks.  These investors tend to start off taking a bit of a “flyer” on investing in single cases where the risk/reward dynamic is asymmetrical, meaning the probability weighted upside is much lower than the probability-weighted downside.  Let’s put some numbers around this concept to illustrate: Assume I have a case that requires $1MM in financing and would pay out as much as $10MM to the funder if the case is successful.  If the probability of winning is 50% and the probability of losing is 50% (as is the case with most trial outcomes), then the probability weighted outcomes are as follows: Losing:       50% * $1,000,000 = $500,000 probability-weighted loss Winning:     50% * $10,000,000 = $5,000,000 probability-weighted win Investors would view these outcomes as asymmetrical meaning the gain that would be generated in a win scenario is multiples of the loss that could get experienced. On the other hand, asymmetric investments are also very attractive to sophisticated hedge funds who get paid to take risk, but in a methodical and calculated way (at least that is the theory). Accordingly, if you look at the early days of the larger fund managers in the asset class, many of them started off by raising capital initially for single cases and eventually for portfolios of investments, as this asset class is particularly well-suited to portfolio theory (as discussed in my three-part series on portfolio theory).  In particular, those hedge funds that had a distressed credit background and who were accustomed to investing in sticky situations involving litigation were particularly comfortable with and attracted to the asset class. While I don’t view the asset class as a “credit” based strategy due to the non-recourse nature of the investments (that is “equity” in my mind), it has nonetheless attracted credit hedge funds. Then there are hedge funds that have more discretion as to what they can invest in, and some of those fund managers invest in debt and equity of public companies where the outcome of a litigation has a significant impact on the value of the underlying securities.  So, while they are investing in publicly-listed securities, they are ultimately making a call on the outcome of the underlying litigation, which is a natural investor for litigation finance given the similarity of the risk/reward profile and their understanding of litigation. Public Markets An interesting dynamic was at play in the early days of litigation finance in the public markets, specifically the UK markets.  Typically, you don’t see business in new industries being established in the public markets (although Canada’s cannabis market would prove me wrong), other than perhaps venture exchanges or through reverse take-overs which create a ‘liquid currency’ (freely tradable shares) to help raise capital, provide investors with liquidity to sell their shares if the thesis was flawed and to use as acquisition currency where an acquisition strategy was relevant. In the UK, litigation finance took a non-conventional path.  First to ‘go public’ was Juridica through a closed-end fund structure.  In speaking with Tim Scrantom, a founder of Juridica and a pioneer in the litigation finance industry, the public vehicle structure was a condition of raising capital from wealth management firms, specifically Neil Woodsford’s Invesco Perpetual fund which could not invest in private structures at the time, but loved the idea behind the litigation finance industry.  With Neil, who was described as the ‘Warren Buffet of the UK’ at the time, the rest of the market followed to the point where Juridica was able to raise a significant amount of capital in a very short period of time, all with the condition that the vehicle be publicly listed to ensure investor liquidity.  With Juridica paving the way for a public listing, and with all of the hype around the opening of the UK litigation finance space, Burford was soon to follow with a more traditional common stock offering. On the other hand, many fund managers who were raising money through private vehicles found it frustrating to raise capital from private individuals as it invariably took a lot of time and attention away from running the operations of the business, and they would ultimately churn through their investors, especially if they didn’t produce sufficient cashflow before their next tranche of investments required capital.  In order to solve the problem of constantly fundraising while scaling their operations, some groups decided to raise permanent capital through public markets.  First to list publicly was Omni Bridgeway in 2001 (formerly IMF Bentham) in Australia, then Juridica in 2008 and Burford Capital in 2009, as previously referenced, and most recently LCM Finance, which originally listed in Australia and then moved executive offices and its listing to the UK markets.  Accordingly, I would suggest there are a disproportionate number of fund managers in litigation finance that are publicly listed in relation to the nascency of the asset class. Many other alternative asset classes have ultimately made their way into public markets, but typically have only sought a public listing when their enterprises approached a sufficient scale such that there was a dependable cycle to their financial results and cashflows and sufficient diversification in their portfolios.  Some litigation finance managers ‘grew up’ in the public markets, which is not always the most comfortable training ground for companies. Nevertheless, the public market participants have so far been successful with a few bumps along the way.  The speed at which litigation finance has tapped the public markets was always a surprise to me, but having undertaken fundraising in the past, I clearly see the benefits of a permanent capital vehicle.  The issue of whether or not litigation finance is an asset class well suited for public markets is a topic for another day, as there is a certain non-recurring nature to the underlying cases and volatility in cashflows that make it a bit of a misfit, but then the attractiveness stems from the non-correlated nature of the investments.  Oddly, being publicly listed adds an element of correlation to an otherwise non-correlated investment. Let’s not even talk about the issue of ‘marking-to-market’ litigation investments, also a topic for another article. The other benefit of having a public vehicle is that it has allowed these managers to issue relatively inexpensive public debt to reduce their overall cost of capital (this issue will be revisited when we speak to the next wave of investors), which would be difficult to impossible in the private markets.  Lastly, most managers have since raised private partnership vehicles to leverage (not in the debt sense of the term) their public equity and to smooth out their earnings, although recently, and surprisingly, some managers are foregoing management fees in exchange for greater upside participation through an enhanced carried interest in the outcomes of their portfolios (which eliminates one of the benefits of using management fees to smooth earnings). The ability for fund managers to raise public capital was also an important evolution for the industry as it brought litigation funding to the forefront within the investment community, and by virtue of their financial disclosure requirements, provided a level of transparency that other litigation funding companies could leverage to raise their own private funds.  Never underestimate the value of data when raising capital. The industry owes a debt of gratitude to the pioneers that broke new ground and laid the foundation for the rest of the industry. Institutional Investors A key part of the evolution of the asset class has also been the active participation of family offices who have made a meaningful impact to the industry.  Some of these family offices, like those that created Vannin and Woodsford, have made a significant investment to the industry by starting and investing in their own litigation finance companies.  Others have decided to construct their own portfolio across a number of different funds and/or managers and strategies to achieve different objectives, with the overarching interest of being exposed to a non-correlated investment strategy that produces strong risk-adjusted returns.  Private equity groups are also actively investing in the sector, either as passive LPs in “blind pool” funds or investing directly into new managers. Endowments and Foundations Within the endowment and foundation world, there is a bifurcation between those groups that are early entrants and those that follow the broader market.  In the litigation finance space, endowments like Yale, Harvard and Columbia, moved decisively a number of years ago to make significant investments in a number of litigation finance managers and continue to invest to this day, which speaks volumes of their experience with the asset class (although it may still be ‘early days’ in terms of fully realized portfolios). Many endowments and foundations have been sitting on the sidelines with good reason.  While the industry has been in existence for upwards of two decades, depending on the jurisdiction, there are few fund managers that have more than one fully realized portfolio (beware duration risk) and many fund managers market their funds off of a handful (or fewer) of case realizations.  Having been on the reviewing side of the ledger, I know enough to know that a few cases does not a fully realized portfolio make.  These investors have been patiently learning and investigating what the asset class is all about and waiting for the best entry point.  I expect to see a whole new series of entrants from the endowment and foundation space as more data is produced by the industry and more comfort is gained from the consistency of returns and manager’s ability to replicate their initial performance (termed “persistency” in private equity circles). Pension Plans and Sovereign Wealth Funds Until recently, it was felt that the industry was not large enough to be attractive to large sovereign wealth funds and pension plans that typically have minimum investment allocations in the hundreds of millions. However, as Burford and Omni Bridgeway have recently launched funds in the $500 million to $1 billion range, we are starting to see interest from this part of the market.  In fact, a sovereign wealth fund, is a single investor in a $667 million separately managed account managed by Burford pursuant to its recent capital raise.  Many of the top five sovereign wealth funds in the world are rumoured to be actively looking at investing in the litigation finance market.  While I expect continued interest, the industry is not so large as to allow for many large sovereign wealth funds and pension plans, and so I don’t expect this to be a large segment of the investing market, as measured by number of investor (but it will be, as measured by dollars).  Of course, the concern with attracting large amounts of capital is that it forces managers to accept larger amounts of capital than they can responsibly invest, which creates distorted incentives and a misalignment between investors and managers.  I hope the industry continues to maintain its discipline in this regard, but I know some will succumb to the lure of larger amounts of capital at their own peril. Beware Conflicts One of the very early entrants into litigation finance in Germany was Allianz, a large German insurance company with over $100 billion in gross written premiums (at the time). It stands to reason that an insurance company would be an early mover in the marketplace as there is no entity better placed than an insurance company to have a significant depth of data about case outcomes upon which they can analyze risk and reward.  The following excerpts are from an article written by Christian Stuerwald of Calunius Capital LLP in January 2012 which aptly describes the reasons for their exit: “The business grew, quickly became profitable and expanded into other jurisdictions, mainly Switzerland, Austria and the UK…. “…, with time and growing market penetration and acceptance the cases became bigger; as claim values grew, so did the size of the defendants,” …”that meant that more and more often cases would be directed against large corporate entities.” “This is really where the problems began, because most corporate entities, certainly the ones that are domiciled in Germany, are customers of Allianz, typically of course in the insurance sector.” “Because of the nature and sheer size of the organisation it was not always easy to detect potential business embarrassment risks in time, as the checks needed to be done on a global basis. This led to some instances where a litigation funding agreement was entered into when it was discovered that the case was directed against a long standing corporate client, who declared himself not amused when the fact of funding was disclosed.” Which led to the ultimate conclusion: “…it was decided to keep the business and place it into run off,”. The same phenomenon applies to hedge funds that have many similar relationship conflicts.  Hedge fund conflict checks have presented significant issues for certain funders who have spent time analyzing cases only to find out at the last minute that the case presents a conflict for their main investor, with many of these investors having veto rights to avoid this very situation.  For funders, this is a bit of a double whammy, as not only are they prevented from making a good investment, but they also suffer reputationally with the law firm that brought them the case, which may have longer term implications for origination. It is my opinion that anyone that imposes investment restrictions on their fund managers will not be long for the world of investing in litigation finance funds, as there will be many new investors that do not impose the same restrictions on their fund managers.  As a fund manager, I would never accept specific case restrictions (other than concentration limits) as they would interfere with my ability to produce returns, foster relationships within the legal community and ultimately make me uncompetitive. I further believe that the investors who invest in hedge funds should not be concerned with the specific contents of the hedge funds’ litigation finance portfolio.  Rather, they should take the enlightened perspective of their investment as a financial hedge against any other pieces of litigation in which they otherwise find themselves (i.e. they may lose their case, but their hedge fund investment just increased in value because it won another litigation).  I think it is naïve to believe a case with good merits will not get funded if one hedge fund does not provide the funding due to a conflict, as meritorious claims are the very reason the industry exists, and so relationship-based restrictions are not effective in the context of the industry.   Nevertheless, capital will chase away restrictions in time, it always does. More Investors are Better The other aspect of the litigation finance community that I have found a bit perplexing is that certain managers, presumably in an effort to expedite their fundraising efforts, have accepted significant investments from one or two large investors, typically hedge funds. On the upside, it makes for a more efficient fundraise – a few meetings and you are done (believe me, I understand the allure).  On the downside, those investors now control your business and have a significant influence on the Management company’s equity value. It has long been known in private equity that you never want a limited partner to ‘own the GP’.  I am not referring to ownership in the traditional sense, although that occurs too.  Rather, in the sense that if you have one or two meaningful investors and they decide to stop funding your business plan, you are then scrambling to find a replacement with a big question mark hanging over the managers’ head – “why did your prior investor stop investing?”. Instead, if you have a broad-based set of investors in your fund (with no single investor providing more than, say, 15% of your capital), you can easily explain why a specific investor exited.  The persistency in capital raising and fund performance is what gives rise to equity value for the GP.  If you don’t have one of the two under your control, the equity value of the GP is significantly impaired. So, my advice to litigation finance managers is to ensure diversification in your investor base as well as your investment portfolio.  Of course, I appreciate that in the early days of a fund manager’s evolution, they may have to accept some investor concentration to establish the business. This is perfectly acceptable as long as the capital doesn’t have too many conditions that limit your ability to raise capital from others in the future. Investors of the future? In the current Covid environment, I would expect to see hedge funds that have increasingly played a role in litigation finance pivot out of litigation finance to chase their more typical distressed credit opportunities that may provide a superior potential return profile. While this dynamic may not last long, it does remove one competitor type from the litigation finance community which should benefit all other litigation finance funders.  For now, I view this as a short-term phenomenon. The more significant trend, I believe, will be the emergence of the pension plans fueled by their relatively low cost of capital.  For pension plans whose cost of capital is dependent on the discount rate applied to their pension liabilities to determine the return profile necessary to ensure the plan remains well capitalized and preferably growing, litigation finance has not been an active investment to date.  However, as more and more data is produced and the level of transparency becomes elevated, pension plans will apply their deep analytical skills to the industry and make the decision that this is a viable asset class in which to invest and has the benefit of non-correlation which may be a very important characteristic depending on the specific plan’s life cycle. I would also expect to see continued strong interest from the endowment, foundation, family office and hedge fund markets as the industry becomes more transparent and data-centric, and the investors that heretofore have been educating themselves about the market start to allocate capital.  I would also not be surprised to see sizable asset managers (think Blackstone, KKR, Apollo, etc.) and sovereign wealth funds enter the market and perhaps even make a move to take some of the publicly listed companies private and internalize the operation so they can not only invest a significant amount of their own money in the platform itself, but also as a permanent vehicle to continue to recycle and compound the returns they are achieving, perhaps at the exclusion of other investors or perhaps as a platform from which to scale further. Of course, technology has traditionally proven to ‘throw a wrench in the works’ by disintermediating many industries, and I expect litigation finance will be no different.  As an example, crowd funding is nascent but becoming a popular investor platform that appears to be attracted to litigation finance.  I say this because I think we need to be open about the possibilities for sources of financing in the future.  I would also look to the private equity markets for guidance in terms of alternative avenues for fundraising as they are some of the more sophisticated alternative investors in the world (in the words of Wayne Gretzky “…skate where the puck is going…”). Investor Insights It perhaps goes without saying that the litigation finance asset class is here to stay.  While there may be challenges, regulatory, judicial and otherwise, the asset class has shown to prevail against formidable challengers to date because the asset class is both efficacious and beneficial for society.  As I have written before, this is an Impact Investing asset class. As the asset class gains scale and awareness, the investor base will change and the changes may be dramatic.  Fund managers who will be raising money should be aware of these changes so they can anticipate and adapt and position their fund offerings to maximize success.  As always, diversification is critical to prudent investing in the asset class, whether from the perspective of fundraising or case investing.  Accordingly, fund managers should be thinking somewhat selfishly about their own equity value when fundraising and investing their capital. Edward Truant is the founder of Slingshot Capital Inc., and an investor in the consumer and commercial litigation finance industry.  Ed is currently designing a product to appeal to institutional investors.
Read More

Is Pharma IP a Viable Asset?

The current trends of litigation related to intellectual property in Pharma indicate an increase in both cost and risk. Does that mean Pharma cases are a bad investment? One might think so, given how complex patents can be, or the increased risk inherent to Pharma regulations. Even successful cases might later be overturned. Burford Capital explains that those who hold or challenge pharmaceutical patents have not gotten fully on board with Litigation Finance as a means to mitigate risk. If a patent lawsuit seems imminent, third-party funding can be a boon. The same applies to those seeking to pursue IP cases. These litigations can be costly, time-consuming, and can carry significant risk. The fact remains that patent infringement can lay waste to a successful brand. Pharma patent cases require specific expertise in order to overcome the challenges of major disputes. Third-party finance can mitigate the risk and keep balance sheets in line. Universities are especially vulnerable to patent infringements. They tend to have far less working capital than big Pharma outfits. The time and money invested in Pharma developments is significant, yet their time and effort may feel wasted when IP makes it all the way to the market via theft. University researchers may be less able to pursue litigation due to money and time constraints, or they may fear risking the reputation of the university if the case is not successful. Risk is still rampant in Pharma patent litigation. But it’s also a wide-open field that can be profitable when experienced funders leverage their expertise to move cases forward.

Funders Defend Agreement in PFAS Contamination Case

A recent Australian class action award has some legal professionals rankled. Should the federal government take a more active role in regulating agreements between plaintiffs, attorneys, and third-party funders? Attorney General Christian Porter thinks so. Katherine Times reports that Porter is irate over funding agreements that ultimately leave ‘members of the action to fight over the scraps.’ That’s a harsh indictment, but is it a fair one? The class-action settlement in question, regarding PFAS contamination in several major areas, led to a settlement of over $212 million. Roughly 40% of the settlement will be taken in cost—so about $86 million. Obviously, the plaintiffs in the case will receive less than they would have without the funding arrangement. Or would they? Chances are that the class action wouldn’t have moved forward at all if not for funding provided by Omni Bridgeway. The funder is due to receive about $54 million in profits and to cover costs from the case. The judge in the case felt that the fees were reasonable, even though the numbers involved are higher than a layperson might expect. Omni Bridgeway has affirmed that in fact, they are taking $35 million less than their contract specifies. The lawyers from Dentons and Shine are also receiving less than expected. The most chilling aspect of the debate over funding is the assertion made by Justice Michael Lee. He suggests that funders may not be as interested in increased access to justice as they are in making money. Well, it’s fair to say that investors have the goal of making money, but it doesn’t naturally follow that this leads to malfeasance or a desire to obtain money that rightfully belongs to plaintiffs. Justice Lee went on to assert that some proceedings appear to be run for the convenience of the funder or attorneys rather than those wronged by the defendants.